{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-084319","form_type":"8-K","ticker":"BDSX","cik":"0001439725","company_name":"BIODESIX INC","filed_at":"2025-04-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.307613+00:00","generated_at":"2026-05-23T11:45:14.103620+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Two Biodesix directors resign effective May 20, 2025; Schuler named director emeritus","bullets":["Charles Watts, M.D. resigns from Board and Compensation Committee effective at 2025 Annual Meeting (May 20, 2025).","Jack Schuler resigns from Board and Nominating & Corporate Governance Committee, transitions to director emeritus (non-voting advisory role).","Both resignations not due to any disagreement with Company's operations, policies, or practices.","Dr. Watts served since July 2019; Mr. Schuler served since June 2008."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-084319","json":"https://secwatch.observer/filing/0001193125-25-084319.json","markdown":"https://secwatch.observer/filing/0001193125-25-084319.md","text":"https://secwatch.observer/filing/0001193125-25-084319.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1439725/000119312525084319/0001193125-25-084319-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1439725/000119312525084319/d861784d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T11:45:14.103620+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a9a04bdcda","claim":"Charles Watts, M.D. resigned as Director at BIODESIX INC.","evidence_excerpt":"On April 15, 2025, Charles Watts, M.D., a member of the Board of Directors (the “Board”) of Biodesix, Inc. (the “Company”), notified the Company of his intention to resign from his position as a director of the Board and as a member of the Compensation Committee, effective at the conclusion of the Company’s 2025 Annual Meeting of Stockholders on May 20, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1439725/000119312525084319/0001193125-25-084319-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}